AU2002349411A1 - Remedies for primary pulmonary hypertension - Google Patents

Remedies for primary pulmonary hypertension

Info

Publication number
AU2002349411A1
AU2002349411A1 AU2002349411A AU2002349411A AU2002349411A1 AU 2002349411 A1 AU2002349411 A1 AU 2002349411A1 AU 2002349411 A AU2002349411 A AU 2002349411A AU 2002349411 A AU2002349411 A AU 2002349411A AU 2002349411 A1 AU2002349411 A1 AU 2002349411A1
Authority
AU
Australia
Prior art keywords
remedies
pulmonary hypertension
primary pulmonary
primary
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002349411A
Inventor
Ichiro Ikegaki
Shin-Ichi Satoh
Hiroaki Shimokawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Pharma Corp
Original Assignee
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Corp, Asahi Chemical Industry Co Ltd filed Critical Asahi Kasei Corp
Publication of AU2002349411A1 publication Critical patent/AU2002349411A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002349411A 2001-11-30 2002-11-21 Remedies for primary pulmonary hypertension Abandoned AU2002349411A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-367144 2001-11-30
JP2001367144 2001-11-30
PCT/JP2002/012154 WO2003047591A1 (en) 2001-11-30 2002-11-21 Remedies for primary pulmonary hypertension

Publications (1)

Publication Number Publication Date
AU2002349411A1 true AU2002349411A1 (en) 2003-06-17

Family

ID=19176934

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349411A Abandoned AU2002349411A1 (en) 2001-11-30 2002-11-21 Remedies for primary pulmonary hypertension

Country Status (3)

Country Link
JP (1) JP4525964B2 (en)
AU (1) AU2002349411A1 (en)
WO (1) WO2003047591A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE551059T1 (en) 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp FASUDIL IN COMBINATION WITH BOSENTAN FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
WO2008049000A2 (en) * 2006-10-18 2008-04-24 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
US20170089924A1 (en) 2014-04-22 2017-03-30 Tohoku University Method of testing for pulmonary hypertension
CN105085478B (en) * 2014-04-28 2019-04-12 南京明德新药研发股份有限公司 Isoquinolin sulphone amide derivative and its pharmaceutical composition and pharmaceutical applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06141894A (en) * 1992-11-11 1994-05-24 Asahi Chem Ind Co Ltd Method for measuring activity of myosin light chain phosphate
EP0956865B2 (en) * 1996-08-12 2010-08-18 Mitsubishi Tanabe Pharma Corporation MEDICINES COMPRISING Rho KINASE INHIBITOR
US6180597B1 (en) * 1998-03-19 2001-01-30 Brigham And Women's Hospital, Inc. Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors
AU4990599A (en) * 1998-07-14 2000-02-07 Brigham And Women's Hospital Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
US6228843B1 (en) * 1999-04-23 2001-05-08 University Technology Corporation Method of using PKC inhibiting compounds to treat vascular disease
TW200400821A (en) * 1999-11-02 2004-01-16 Pfizer Pharmaceutical composition (II) useful for treating or preventing pulmonary hypertension in a patient

Also Published As

Publication number Publication date
JPWO2003047591A1 (en) 2005-04-14
WO2003047591A1 (en) 2003-06-12
JP4525964B2 (en) 2010-08-18

Similar Documents

Publication Publication Date Title
AU2002245293A1 (en) Integrated transformer
AU2002352444A1 (en) Quinazolinedione derivatives
AU2002345632A1 (en) Tackifier composition
AU2002308237A1 (en) Value document
AU2002300754A1 (en) New Combination
AUPR878201A0 (en) New compounds
AU2002359464A1 (en) Angiopioetin related factors
AU2002254232A1 (en) Photoresist composition
AU2001258836A1 (en) Preventives and remedies for pulmonary hypertension
AU2002349411A1 (en) Remedies for primary pulmonary hypertension
AU2002214681A1 (en) Hypertension
AU2002334846A1 (en) Elastase inhibitors
AU2003211254A1 (en) Remedy for hypertension
AU2002238962A1 (en) Remedies for arteriosclerosis
AU2002316624A1 (en) Aluminum paper
AU2002243901A1 (en) Transition strip for disparate concrete forms
AUPR584101A0 (en) Improved paperboard
AUPR601001A0 (en) Wedge
AU2002332171A1 (en) Remedies
AU2002244927A1 (en) Remedies
AU2002318557A1 (en) Remedies
AU2002255320A1 (en) Remedies for sepsis
AU2002228390A1 (en) Remedies for hyponutrition status
AU2002256828A1 (en) Folding anchor
AUPR652101A0 (en) Truss

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase